Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 17,676–17,700 of 27,380 studies, newest first · page 708 of 1096.

August 2014 25

  1. 2014-08-14
  2. 2014-08-13

    Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease

    ✓ Peer-reviewed Biomarkers ACS chemical neuroscience

    Key finding: We used an immunomagnetic reduction assay to measure the plasma levels of Aβ40, Aβ42, and tau proteins in 20 older control participants and 25 participants who had either mild cognitive impairment due to AD or early AD dementia. +4 more findings

  3. 2014-08-13

    The pattern and loci of training-induced brain changes in healthy older adults are predicted by the nature of the intervention

    ✓ Peer-reviewed Prevention trials PloS one

    Key finding: The few studies that have looked at brain correlates of cognitive training indicate a variable pattern and location of brain changes--a result that might relate to differences in training formats.

  4. 2014-08-13

    Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly

    ✓ Peer-reviewed Digital health tools Gerontology

    Key finding: The fall detection system detected 12 out of 15 real-life falls, having a sensitivity of 80.0%, with a false alarm rate of 0.049 alarms per usage hour with the implemented real-time system. +2 more findings

  5. 2014-08-13

    CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment Journal of neurology, neurosurgery, and psychiatry

    Key finding: Moreover, we found, in either the whole AD population or both subgroups, a CSF profile in which higher +3 more findings

  6. 2014-08-12

    Increased risk of dementia in patients exposed to nitrogen dioxide and carbon monoxide: a population-based retrospective cohort study

    ✓ Peer-reviewed Risk factors PloS one

    Key finding: The results of this large retrospective, population-based study indicate that exposure to NO2 and CO is associated with an increased risk of dementia in the Taiwanese population. +2 more findings

  7. 2014-08-12

    Plasma DYRK1A as a novel risk factor for Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Translational psychiatry

    Key finding: In plasma from AD patients, DYRK1A levels were significantly lower compared with controls (P<0.0001). +3 more findings

  8. 2014-08-12

    MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease

    ✓ Peer-reviewed Genetics Molecular medicine reports

    Key finding: In the present study, bioinformatic analyses showed that miR‑193b was a miR that was predicted to potentially target the 3'‑untranslated region (UTR) of APP. +4 more findings

  9. 2014-08-11

    Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis

    ✓ Peer-reviewed Vascular contributions Ageing research reviews

    Key finding: Large cohort studies have revealed a relationship among increased risk for cognitive impairment and dementia in cardiovascular diseases probably due to embolic stroke or chronic cerebral hypoperfusion.

  10. 2014-08-11
  11. 2014-08-08

    Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

    ✓ Peer-reviewed Drug development Neuropharmacology

    Key finding: We have previously shown that liraglutide showed neuroprotective effects in the APPswe/PS1ΔE9 mouse model of AD. +2 more findings

  12. 2014-08-07

    Using virtual reality for cognitive training of the elderly

    ✓ Peer-reviewed Prevention trials American journal of Alzheimer's disease and other dementias

    Key finding: Meeting that demand can significantly benefit from the deployment of innovative, computer-based applications capable of addressing specific needs, particularly in the area of cognitive impairment mitigation and rehabilitation.

  13. 2014-08-07

    Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients

    ✓ Peer-reviewed Inflammation and the immune system Acta neuropathologica communications

    Key finding: Little is known, however, about the different phenotypes of microglia and how they change during disease progression, in the SN or in another brain region, like the hippocampus (HC), which is implicated in dementia and depression, important non-motor symptoms in PD. +3 more findings

  14. 2014-08-07

    C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins

    ✓ Peer-reviewed Lewy body dementia Science (New York, N.Y.)

    Key finding: Expression of individual dipeptide repeat proteins with a non-GGGGCC RNA sequence revealed that both poly-(glycine-arginine) and poly-(proline-arginine) proteins caused neurodegeneration. +1 more finding

  15. 2014-08-06

    Vitamin D and the risk of dementia and Alzheimer disease

    ✓ Peer-reviewed Vascular contributions Neurology

    Key finding: Our results confirm that vitamin D deficiency is associated with a substantially increased risk of all-cause dementia and Alzheimer disease. +4 more findings

  16. 2014-08-06

    Pathological alpha-synuclein propagates through neural networks

    ✓ Peer-reviewed Brain tissue and pathology Acta neuropathologica communications

    Key finding: α-Synuclein is the major component of filamentous inclusions that constitute the defining characteristic of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy, so-called α-synucleinopathies. +3 more findings

  17. 2014-08-05

    Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression

    ✓ Peer-reviewed Digital health tools Molecular psychiatry

    Key finding: Our aim was to evaluate peripheral (blood-based) evidence for biological pathways associated with cognitive impairment in older adults with LLD. +4 more findings

  18. 2014-08-04

    Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease

    ✓ Peer-reviewed Tau biomarkers Neurobiology of aging

    Key finding: CSF α-syn and Aβ₁₋₄₂ were significantly lower in PD compared with controls. +3 more findings

  19. 2014-08-04

    Not only cardiovascular, but also coordinative exercise increases hippocampal volume in older adults

    ✓ Peer-reviewed Hippocampus size on brain scans Frontiers in aging neuroscience

    Key finding: Cardiovascular activity has been shown to be positively associated with gray and white matter volume of, amongst others, frontal and temporal brain regions in older adults. +3 more findings

  20. 2014-08-04

    Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in cellular neuroscience

    Key finding: It is mainly composed of endothelial cells (ECs), pericytes and astrocytes that create a neurovascular unit (NVU) with the adjacent neurons. +3 more findings

  21. 2014-08-04

    Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease

    ✓ Peer-reviewed Genetics Neurobiology of aging

    Key finding: APOE-e4 associated with worse baseline memory and increased decline with highly significant overall effect on memory. +4 more findings

  22. 2014-08-01

    Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease

    ✓ Peer-reviewed Treatments Expert review of neurotherapeutics

    Key finding: Among active and passive anti-β-amyloid (Aβ) immunotherapies for Alzheimer's disease (AD), bapineuzumab and solanezumab, two humanized monoclonal antibodies, failed to show significant clinical benefits in mild-to-moderate AD patients in large Phase III clinical trials. +1 more finding

  23. 2014-08-01

    Haptoglobin interacts with apolipoprotein E and beta-amyloid and influences their crosstalk

    ✓ Peer-reviewed Genetics ACS chemical neuroscience

    Key finding: Our data suggest that haptoglobin and ApoE functions in brain should be evaluated taking into account their mutual interaction with beta-amyloid.

  24. 2014-08-01

    Multiple chronic conditions and life expectancy: a life table analysis

    ✓ Peer-reviewed Costs and economics Medical care

    Key finding: Social Security and Medicare actuaries should account for the growing number of beneficiaries with multiple chronic conditions when determining population projections and trust fund solvency. +1 more finding

  25. 2014-08-01

    Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice

    ✓ Peer-reviewed Drug development Journal of neurochemistry

    Key finding: These results show that passive immunization targeting tau can modulate aspects of tau pathology in tau transgenic mouse models, in an antibody isotype-specific manner.

Browse the library by subject, with the full score breakdown →